News
For more than 25 years, the local community has gathered at the annual Walk to Defeat ALS Johnstown event, and for nearly that entire time, Jeremy Portash has been involved. He and his family, who ...
Movies on Netflix are like Houdini's props. One moment they're there, the next moment they aren't. Check out these horror movies before they leave.
US FDA grants orphan drug designation to Klotho Neurosciences’ KLTO-202 to treat amyotrophic lateral sclerosis: New York Saturday, July 12, 2025, 15:00 Hrs [IST] Klotho Neurosci ...
In a powerful act of compassion and community, Starr’s Mill High School organized an early graduation for rising senior ...
Detailed price information for Klotho Neurosciences Inc (KLTO-Q) from The Globe and Mail including charting and trades.
In 2023, Chantler took it upon himself to look for a specialized mobility device called a 'TrailRider' to rent for an outdoor ...
A coalition of ALS patients and caregivers is petitioning the FDA to review available data on the stem cell therapy NurOwn ...
Stem cell tech simulates ALS, quantum tools decode quasicrystals, and cancer exploits a human mutation—three breakthroughs ...
In total, 11 abstracts on givinostat were accepted for presentation at the Congress, including two for an oral presentation ...
Neurizon Therapeutics has announced it has received positive feedback from the US Food and Drug Administration (FDA) on its ...
Documenting his experiences has proven to be the outlet Darin Nakakihara needs in the wake of his ALS diagnosis.
3d
InvestorsHub on MSNKlotho Neurosciences Shares Jump as FDA Grants Orphan Drug Status for ALS TherapyShares of Klotho Neurosciences, Inc. (NASDAQ:KLTO) surged 22% following news that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to the company’s gene therapy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results